EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 16 filers reported holding EVOGENE LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -53.8% | 4,541 | -44.7% | 0.00% | – |
| Q4 2021 | $13,000 | +333.3% | 8,206 | +799.8% | 0.00% | – |
| Q2 2021 | $3,000 | -40.0% | 912 | -19.9% | 0.00% | – |
| Q4 2020 | $5,000 | +66.7% | 1,139 | +75.5% | 0.00% | – |
| Q3 2020 | $3,000 | +200.0% | 649 | +549.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 100 | +25.0% | 0.00% | – |
| Q3 2016 | $1,000 | -80.0% | 80 | -90.4% | 0.00% | – |
| Q2 2016 | $5,000 | -37.5% | 832 | -31.4% | 0.00% | -100.0% |
| Q1 2016 | $8,000 | -20.0% | 1,213 | -0.6% | 0.00% | -50.0% |
| Q4 2015 | $10,000 | +900.0% | 1,220 | +1120.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 100 | -33.3% | 0.00% | – |
| Q2 2015 | $1,000 | -83.3% | 150 | -77.1% | 0.00% | -100.0% |
| Q1 2015 | $6,000 | 0.0% | 656 | +9.3% | 0.00% | 0.0% |
| Q4 2014 | $6,000 | -33.3% | 600 | -14.3% | 0.00% | 0.0% |
| Q3 2014 | $9,000 | +50.0% | 700 | +133.3% | 0.00% | 0.0% |
| Q4 2013 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eidelman Virant Capital | 117,000 | $101,000 | 0.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,322 | $156,000 | 0.05% |
| Senvest Management, LLC | 230,606 | $178,000 | 0.01% |
| Susquehanna International Group Ltd. | 28,718 | $21,000 | 0.01% |
| Vident Investment Advisory, LLC | 87,714 | $68,000 | 0.00% |
| MGO ONE SEVEN LLC | 15,340 | $12,000 | 0.00% |
| Csenge Advisory Group | 31,962 | $24,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $8,000 | 0.00% |
| Sigma Planning Corp | 31,810 | $24,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,249 | $8,000 | 0.00% |